The global DNA diagnostics market size was USD 10.70 billion in 2023, calculated at USD 11.16 billion in 2024 and is expected to be worth around USD 17billion by 2034. The market is slated to expand at 4.3% CAGR from 2024 to 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on DNA Diagnostics Market
5.1. COVID-19 Landscape: DNA Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global DNA Diagnostics Market, By Product Type
8.1. DNA Diagnostics Market, by Product Type, 2024-2034
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Reagents
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Service & Software
8.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global DNA Diagnostics Market, By Technology
9.1. DNA Diagnostics Market, by Technology, 2024-2034
9.1.1. PCR
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Microarray
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. In-situ Hybridization
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Sequencing Technology
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Mass Spectrometry
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global DNA Diagnostics Market, By Application
10.1. DNA Diagnostics Market, by Application, 2024-2034
10.1.1. Oncology
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Infectious Disease
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Myogenic Disorder
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Clinical Diagnostic Confirmation
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Prenatal Diagnostics
10.1.5.1. Market Revenue and Forecast (2021-2034)
10.1.6. Pre-implantation Diagnostics
10.1.6.1. Market Revenue and Forecast (2021-2034)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global DNA Diagnostics Market, By End-user
11.1. DNA Diagnostics Market, by End-user, 2024-2034
11.1.1. Point of Care
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Diagnostic Center
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Self-Testing/OTC
11.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 12. Global DNA Diagnostics Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.1.2. Market Revenue and Forecast, by Technology (2021-2034)
12.1.3. Market Revenue and Forecast, by Application (2021-2034)
12.1.4. Market Revenue and Forecast, by End-user (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End-user (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.2.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.4. Market Revenue and Forecast, by End-user (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End-user (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End-user (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End-user (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.3.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.4. Market Revenue and Forecast, by End-user (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End-user (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End-user (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End-user (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.4.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.4. Market Revenue and Forecast, by End-user (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End-user (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End-user (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End-user (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End-user (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product Type (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End-user (2021-2034)
Chapter 13. Company Profiles
13.1. Thermo Fisher Scientific Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. QIAGEN
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Beckman Coulter Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Agilent Technologies Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. GE Healthcare
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Illumina Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Cepheid.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Hologic, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Siemens HealthcareGmbH
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. F. Hoffmann-La Roche
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Term
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample